The role of reticulons in neurodegenerative diseases

V Chiurchiu, M Maccarrone, A Orlacchio - Neuromolecular medicine, 2014 - Springer
Reticulons (RTNs) are a group of membrane-associated proteins mainly responsible for
sha** the tubular endoplasmic reticulum network, membrane trafficking, inhibition of …

Nogo-A antibodies for progressive multiple sclerosis

BV Ineichen, PS Plattner, N Good, R Martin… - CNS drugs, 2017 - Springer
Most of the current therapies, as well as many of the clinical trials, for multiple sclerosis (MS)
target the inflammatory autoimmune processes, but less than 20% of all clinical trials …

Nogo-A antibodies enhance axonal repair and remyelination in neuro-inflammatory and demyelinating pathology

BV Ineichen, S Kapitza, C Bleul, N Good… - Acta …, 2017 - Springer
Two hallmarks of chronic multiple sclerosis lesions are the absence of significant
spontaneous remyelination and primary as well as secondary neurodegeneration. Both …

Metformin-induced AMPK activation stimulates remyelination through induction of neurotrophic factors, downregulation of NogoA and recruitment of Olig2+ precursor …

F Houshmand, M Barati, F Golab… - DARU Journal of …, 2019 - Springer
Abstract Purpose Oligodendrocytes (OLGs) damage and myelin distraction is considered as
a critical step in many neurological disorders especially multiple sclerosis (MS). Cuprizone …

Nogo receptor inhibition enhances functional recovery following lysolecithin-induced demyelination in mouse optic chiasm

F Pourabdolhossein, S Mozafari, G Morvan-Dubois… - PloS one, 2014 - journals.plos.org
Background Inhibitory factors have been implicated in the failure of remyelination in
demyelinating diseases. Myelin associated inhibitors act through a common receptor called …

How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?

Z Rashidbenam, E Ozturk, M Pagnin… - Frontiers in Cellular …, 2023 - frontiersin.org
Multiple sclerosis (MS) can progress with neurodegeneration as a consequence of chronic
inflammatory mechanisms that drive neural cell loss and/or neuroaxonal dystrophy in the …

Exercise modulates the levels of growth inhibitor genes before and after multiple sclerosis

SH Shahidi, MR Kordi, H Rajabi, C Malm… - Journal of …, 2020 - Elsevier
Multiple sclerosis (MS) is a neurodegenerative disease of the central nervous system. The
animal model of MS, experimental autoimmune encephalomyelitis (EAE), is commonly used …

[HTML][HTML] Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

D Nheu, O Ellen, S Ye, E Ozturk, M Pagnin… - Cells, 2022 - mdpi.com
Current therapeutics targeting chronic phases of multiple sclerosis (MS) are considerably
limited in reversing the neural damage resulting from repeated inflammation and …

B-cells expressing NgR1 and NgR3 are localized to EAE-induced inflammatory infiltrates and are stimulated by BAFF

MM Bakhuraysah, P Theotokis, JY Lee, AA Alrehaili… - Scientific reports, 2021 - nature.com
We have previously reported evidence that Nogo-A activation of Nogo-receptor 1 (NgR1)
can drive axonal dystrophy during the neurological progression of experimental …

Protocadherins in neurological diseases

T Hirabayashi, T Yagi - Cell Adhesion Molecules: Implications in …, 2013 - Springer
Cadherins were originally isolated as calcium-dependent cell adhesion molecules and are
characterized by their cadherin motifs in the extracellular domain. In vertebrates, including …